help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caron, P.
Right arrow Articles by Rochiccioli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caron, P.
Right arrow Articles by Rochiccioli, P.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 10 3563-3569
Copyright © 1999 by The Endocrine Society


Original Studies

Combined Hypothalamic-Pituitary-Gonadal Defect in a Hypogonadic Man with a Novel Mutation in the DAX-1 Gene1

Philippe Caron, Sandrine Imbeaud, Antoine Bennet, Monique Plantavid, Giovanna Camerino and Pierre Rochiccioli

Service d’Endocrinologie et Maladies Métaboliques, CHU Rangueil (P.C., A.B.), 31054 Toulouse, France; Biologia Generale e Genetica Medica, Università di Pavia (S.I., G.C.), 27100 Pavia, Italy; Laboratoire de Biochimie, CHU La Grave (M.P.), and Service de Pédiatrie et Génétique Médicale, CHU Purpan (P.R.), Toulouse, France

Address all correspondence and requests for reprints to: Philippe Caron, M.D., Service d’Endocrinologie, CHU Rangueil, 1 avenue J. Poulhes, 31054 Toulouse Cedex, France. E-mail: caron.p{at}chu-toulouse.fr

We have studied a 20-yr-old male patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism (HH) due to a C to A transversion at nucleotide 825 in the DAX-1 gene, resulting in a stop codon at position 197. The same mutation was detected in his affected first cousin (adrenal hypoplasia congenita and HH) and in a heterozygous state in their carrier mothers. The patient had had acute adrenal insufficiency at the age of 2 yr and 6 months, bilateral cryptorchidism corrected surgically at the age of 12 yr, and failure of spontaneous puberty. Plasma testostereone (T) was undetectable (<0.30 nmol/L), gonadotropin levels were low (LH, <0.4 IU/L; FSH, 1.5 IU/L) and not stimulated after iv injection of 100 µg GnRH. The endogenous LH secretory pattern was apulsatile, whereas free {alpha}-subunit (FAS) levels depicted erratic pulses, suggesting an incomplete deficiency of hypothalamic GnRH secretion. During iv pulsatile GnRH administration (10 µg/pulse every 90 min for 40 h), each GnRH pulse induced a LH response of low amplitude (0.54 ± 0.05 UI/L), whereas mean LH (0.45 ± 0.01 IU/L) and FAS (63 ± 8 mU/L) levels remained low. Amplitude of LH peaks (0.83 ± 0.09 IU/L), mean LH (0.53 ± 0.02 IU/L), and FAS (161 ± 18 mU/L) levels increased (P < 0.01), whereas the T concentration remained low (0.75 nmol/L) when the pulsatile GnRH regimen was raised to 20 µg/pulse for a 40-h period, suggesting a partial pituitary resistance to GnRH. Thereafter, plasma T levels remained in prepubertal value after three daily im injections of 5000 IU hCG (3.6 nmol/L) and after 1-yr treatment with weekly im injections of 1500 IU hCG (1.2 nmol/L), implying Leydig cell resistance to hCG. The patient had a growth spurt, bone maturation, progression of genital and pubic hair stages, and normalization of plasma T level (15.8 nmol/L) after a 12-month treatment with twice weekly injections of hCG and human menopausal gonadotropin (75 IU International Reference Preparation 2) preparations, suggesting that, in presence of FSH, a Sertoli cell-secreted factor stimulated Leydig cell production of T. In conclusion, we report a novel mutation in the DAX-1 gene in patients with AHC and HH. Our results suggest that the hypogonadism is due to a combined hypothalamic-pituitary-gonadal defect and imply that the DAX-1 gene may play a critical role in human testicular function.




This article has been cited by other articles:


Home page
EDUCATION AND PRACTICEHome page
C Russo, E J Davis, P R Betts, and J H Davies
The importance of re-evaluation, re-investigation and follow-up of adrenal insufficiency
Arch. Dis. Child. Ed. Pract., August 1, 2007; 92(4): ep109 - ep113.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. J. Meeks, T. A. Russell, B. Jeffs, I. Huhtaniemi, J. Weiss, and J. L. Jameson
Leydig Cell-Specific Expression of DAX1 Improves Fertility of the Dax1-Deficient Mouse
Biol Reprod, July 1, 2003; 69(1): 154 - 160.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Brown, G. A. Scobie, J. Townsend, R. A. L. Bayne, J. R. Seckl, P. T. K. Saunders, and R. A. Anderson
Identification of a Novel Missense Mutation That Is as Damaging to DAX-1 Repressor Function as a Nonsense Mutation
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1341 - 1349.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. J. Tremblay and R. S. Viger
Nuclear Receptor Dax-1 Represses the Transcriptional Cooperation Between GATA-4 and SF-1 in Sertoli Cells
Biol Reprod, April 1, 2001; 64(4): 1191 - 1199.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society